TAIZHOU, China, Jan. 30, 2026 (GLOBE NEWSWIRE) — China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company” or “SXTC”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today…
China SXT Pharmaceuticals (NASDAQ: SXTC) announced an AI Insight Initiative to explore applying artificial intelligence and digital tools across its Traditional Chinese Medicine raw-material supply chain. The company plans to evaluate AI-supported methods for cultivation environment monitoring, origin and authenticity assessment, quality evaluation and grading, and supply-demand forecasting and circulation efficiency. The stated…
TAIZHOU, China, Jan. 08, 2026 (GLOBE NEWSWIRE) — China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”),…